Creative Medical Technology Holdings, Inc. (CELZ) vs Moleculin Biotech, Inc. (MBRX)
A side-by-side comparison of Creative Medical Technology Holdings, Inc. and Moleculin Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELZ
Creative Medical Technology Holdings, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 10:36 AM EDT
MBRX
Moleculin Biotech, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 10:38 AM EDT
Total return — CELZ vs MBRX
growth of $100 · dividends reinvested · last 10yCELZ -100.0% (-72.6%/yr)MBRX -100.0% (-64.0%/yr)MBRX compounded faster over this window
Log scale — wide-divergence pair
CELZ MBRX
CELZ vs MBRX: by the numbers
- •MBRX is the larger company ($2M vs $2M market cap).
- •Both run net losses; MBRX's is the smaller (0.00% vs -201355.37% net margin).
Metrics side by side
Valuation
| Metric | CELZ | MBRX |
|---|---|---|
| P/S ratio | 774.20 | N/A |
| P/B ratio | 0.27 | 0.21 |
Profitability
| Metric | CELZ | MBRX |
|---|---|---|
| Gross margin | 63.43% | 0.00% |
| Operating margin | -102380.23% | 0.00% |
| Net margin | -201355.37% | 0.00% |
| ROE | -69.79% | -261.73% |
| ROIC | -71.90% | -242.25% |
Growth (annualized)
| Metric | CELZ | MBRX |
|---|---|---|
| Revenue CAGR (5Y) | -50.85% | N/A |
| Total return CAGR (5Y) | -57.96% | -78.48% |
Frequently asked
- How have CELZ and MBRX total returns compared?
- Over the past 10 years, CELZ delivered -72.19% and MBRX delivered -64.00% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.